BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 34586495)

  • 21. [The diagnosis and treatment of G3 neuroendocrine tumors according to the new NCCN guideline].
    Liang Y; Yu XJ; Chen J
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):982-987. PubMed ID: 35399015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors.
    Barrea L; Muscogiuri G; Modica R; Altieri B; Pugliese G; Minotta R; Faggiano A; Colao A; Savastano S
    Front Endocrinol (Lausanne); 2021; 12():649496. PubMed ID: 33815296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of Interventional Radiology in the management of Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NETs).
    Orgera G; Krokidis M; Cappucci M; Gourtsoyianni S; Tipaldi MA; Hatzidakis A; Rebonato A; Rossi M
    Cardiovasc Intervent Radiol; 2015 Feb; 38(1):13-24. PubMed ID: 25366087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms.
    Alexandraki KI; Karapanagioti A; Karoumpalis I; Boutzios G; Kaltsas GA
    Biomed Res Int; 2017; 2017():9856140. PubMed ID: 29349087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroendocrine gastro-entero-pancreatic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Öberg K; Knigge U; Kwekkeboom D; Perren A;
    Ann Oncol; 2012 Oct; 23 Suppl 7():vii124-30. PubMed ID: 22997445
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic Treatment of Advanced Gastroenteropancreatic Neuroendocrine Tumors in Korea: Literature Review and Expert Opinion.
    Yoo C; Oh CR; Kim ST; Bae WK; Choi HJ; Oh DY; Lee MA; Ryoo BY
    Cancer Res Treat; 2021 Apr; 53(2):291-300. PubMed ID: 33421978
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)].
    Kos-Kudła B; Bolanowski M; Handkiewicz-Junak D; Jarzab B; Królicki L; Krzakowski M; Kunikowska J; Nasierowska-Guttmejer A; Nowak A; Rydzewska G; Starzyńska T; Szawłowski A;
    Endokrynol Pol; 2008; 59(1):41-56. PubMed ID: 18335400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations.
    Elvebakken H; Perren A; Scoazec JY; Tang LH; Federspiel B; Klimstra DS; Vestermark LW; Ali AS; Zlobec I; Myklebust TÅ; Hjortland GO; Langer SW; Gronbaek H; Knigge U; Tiensuu Janson E; Sorbye H
    Neuroendocrinology; 2021; 111(9):883-894. PubMed ID: 33002892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
    Rinke A; Auernhammer CJ; Bodei L; Kidd M; Krug S; Lawlor R; Marinoni I; Perren A; Scarpa A; Sorbye H; Pavel ME; Weber MM; Modlin I; Gress TM
    Gut; 2021 Sep; 70(9):1768-1781. PubMed ID: 33692095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gastroenteropancreatic neuroendocrine tumors : targeted diagnostics and therapy].
    Holzer K
    Chirurg; 2014 Aug; 85(8):731-44. PubMed ID: 25103842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors.
    Sclafani F; Carnaghi C; Di Tommaso L; Rodari M; Destro A; Rimassa L; Giordano L; Chiti A; Roncalli M; Santoro A
    Tumori; 2011; 97(5):620-8. PubMed ID: 22158494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Precision medicine in gastroenteropancreatic neuroendocrine neoplasms: Where are we in 2023?
    Fazio N; La Salvia A
    Best Pract Res Clin Endocrinol Metab; 2023 Sep; 37(5):101794. PubMed ID: 37414651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center.
    Lewkowicz E; Trofimiuk-Müldner M; Wysocka K; Pach D; Kiełtyka A; Stefańska A; Sowa-Staszczak A; Tomaszewska R; Hubalewska-Dydejczyk A
    Pol Arch Med Wewn; 2015; 125(5):337-46. PubMed ID: 25924181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New molecular aspects for the diagnosis and treatment of neuroendocrine gastroenteropancreatic tumors.
    Wiedenmann B; Ahnert-Hilger G; Kvols LK; Riecken EO
    Ann N Y Acad Sci; 1994 Sep; 733():515-25. PubMed ID: 7978902
    [No Abstract]   [Full Text] [Related]  

  • 35. Update on gastroenteropancreatic neuroendocrine tumors.
    Andreasi V; Partelli S; Muffatti F; Manzoni MF; Capurso G; Falconi M
    Dig Liver Dis; 2021 Feb; 53(2):171-182. PubMed ID: 32912771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastroenteropancreatic Neuroendocrine Tumors.
    Kotagal M; von Allmen D
    Semin Pediatr Surg; 2020 Jun; 29(3):150928. PubMed ID: 32571513
    [No Abstract]   [Full Text] [Related]  

  • 37. Hegemony and cost-effectiveness of endoscopic ultrasound (EUS) in the field of gastroenteropancreatic-neuroendocrine tumors (GEP-NETs).
    De Angelis C; Manfrè SF; Bruno M; Pellicano R
    Minerva Med; 2014 Oct; 105(5):363-70. PubMed ID: 25325565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.
    Zhang X; Ma L; Bao H; Zhang J; Wang Z; Gong P
    BMC Endocr Disord; 2014 Jul; 14():54. PubMed ID: 25001493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State of the Art in Endoscopic Therapy for the Management of Gastroenteropancreatic Neuroendocrine Tumors.
    Papaefthymiou A; Laskaratos FM; Koffas A; Manolakis A; Gkolfakis P; Coda S; Sodergren M; Suzuki N; Toumpanakis C
    Curr Treat Options Oncol; 2022 Jul; 23(7):1014-1034. PubMed ID: 35511346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours).
    Kos-Kudła B; Blicharz-Dorniak J; Handkiewicz-Junak D; Jarząb B; Jarząb M; Kunikowska J; Kuśnierz K; Król R; Królicki L; Krzakowski M; Nasierowska-Guttmejer A; Nowakowska-Duława E; Patkowski W; Szawłowski AW; ;
    Endokrynol Pol; 2013; 64(6):418-43. PubMed ID: 24431116
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.